Sentence examples for more recent chemotherapy from inspiring English sources

Details are as reported previously, though this was updated to encompass more recent chemotherapy agents.

Differences could be due to the inclusion in our study of a larger number of survivors treated on more recent chemotherapy protocols.

In general, it appears that more recent chemotherapy regimens that employ platinum compounds, and often etoposide or taxanes or both (Briasoulis et al, 1998a; Briasoulis et al, 2000; Saghatchian et al, 2001; Greco et al, 2001a) are superior, in terms of response rate, to more traditional drugs (Kelsen et al, 1992; Nole et al, 1993; Falkson and Cohen, 1998; Lofts et al, 1999).

[ 3] Although the large chemotherapy versus BSC trials, and the more recent combination chemotherapy trials, reported a significant benefit from chemotherapy in both survival and quality of life in advanced NSCLC, all were performed in relatively young, highly selected groups of patients.

Possibly, more recent regimens of chemotherapy developed for gastric cancer or novel therapies also directed against quiescent cells could further increase eradication rates for ITC.

Analyses of risk in patients treated in the more recent past with chemotherapy combinations that do not cause ovarian failure, such as adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) (Santoro et al, 1982), may help to clarify this issue.

Elevated s-FSH and/or low s-inhibin B have, however, been reported 5 years or more following chemotherapy in more recent studies, in which the chemotherapy doses were not specified (Huddart et al, 2005; Nuver et al, 2005).

As compared with those without, patients with recent chemotherapy more often had a high-grade malignancy (P < 0.001), were more often neutropenic (P < 0.001), less often had pulmonary infiltrates (P = 0.007), and less often required mechanical ventilation (P = 0.04).

A more recent theory is that chemotherapy would induce hyperphagia (Demark-Wahnefried et al. 1993).

Further support came from the more recent finding that intraperitoneal chemotherapy is equivalent and even superior to systemic therapy in this disease (Armstrong et al, 2006).

More recent evidence suggests that chemotherapy for oestrogen receptor-negative cancers in the elderly may confer a survival advantage (International Breast Cancer Study Group, 2002).